RT Book, Section
A1 Mark, Daniel B.
A2 Fuster, Valentin
A2 Harrington, Robert A.
A2 Narula, Jagat
A2 Eapen, Zubin J.
SR Print(0)
ID 1191189649
T1 ECONOMICS AND COST-EFFECTIVENESS IN CARDIOLOGY
T2 Hurst's The Heart, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843249
LK accesscardiology.mhmedical.com/content.aspx?aid=1191189649
RD 2024/04/20
AB SummaryThis  chapter  describes  the  discipline  of  health  economics  and  the  useful  role  it  may  have  in  debates  about  dealing  with  the  ever-rising  costs  of  the  medical  care  system.  The  chapter  also  reviews  the  health  economics  of  specific  therapies  and  strategies  used  in  the  care  of  patients  with  heart  failure,  atrial  fibrillation,  and  coronary  artery  disease.  Widespread  concern  exists  about  the  current  and  future  costs  of  health  care,  and  uncertainty  about  the  best  way  to  control  these  costs  is  tremendous.  Health  economics  is  the  study  of  the  production  and  allocation  of  health  care  resources,  and  is  based  on  the  ideas  that  society’s  collective  resources  are  finite  and  that  choices  need  to  be  made  about  the  best  ways  to  use  these  limited  resources  to  fulfill  the  needs  and  desires  of  society.  Three  critical  questions  exist  for  health  economics  (see  accompanying  Hurst’s  Central  Illustration):  (1)  What  long-term  effects  does  it  have  on  health  outcomes,  and  what  is  the  level  of  evidence  supporting  the  current  state  of  understanding  about  clinical  effectiveness?  (2)  Is  it  good  value  for  money?  (3)  Can  we  afford  it?  Notably,  the  value  of  economic  analysis  is  highly  dependent  on  the  quality  and  relevance  of  the  data  available  for  the  work;  much  modeling  is  performed  because  clinical  studies  rarely  provide  all  the  data  that  are  needed  for  a  comprehensive  health  economics  analysis.